Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site. # Vesalio Vesalio Acute Ischemic Stroke ## Sitemaps - [XML Sitemap](https://www.vesalio.com/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [NeVa Product Family Roll Up Banners](https://www.vesalio.com/neva-product-family-roll-up-banners/) - Product brochure to be used as leave behind piece as needed. - [Vesalio Announces Late-Breaking Clinical Trial Presentation of the enVast NATURE Study at the ESC Congress 2026](https://www.vesalio.com/vesalio-announces-late-breaking-clinical-trial-presentation-of-the-envast-nature-study-at-the-esc-congress-2026/) - NATURE trial, a prospective randomized controlled trial comparing the safety and effectiveness of thrombectomy using enVast before conventional PCI versus standard of care alone, was selected for the prestigious Late-Breaking Clinical Trials session at the European Society of Cardiology Congress. - [Vesalio Appoints Greg Cook as Chief Commercial Officer](https://www.vesalio.com/vesalio-appoints-greg-cook-as-chief-commercial-officer/) - Greg Cook joins Vesalio as Chief Commercial Officer to lead commercial strategy and execution across its thrombectomy platform. - [07. VESALIO NEVA PRODUCT FAMILY ROLL UP BANNERS](https://www.vesalio.com/vesalio-neva-and-neva-net-roll-up-banner/) - PDF to download for printing of roll up banners to use at local meetings and events - [02. NeVa & NeVa NET Product Brochure](https://www.vesalio.com/neva-and-neva-net-brochure/) - Product brochure to be used as leave behind piece as needed. This brochure includes both NeVa and NeVa NET codes. - [Vesalio Expands International Neurovascular Portfolio with CE Mark of NeVa VS and NeVa 3.0 mm and Receives Additional FDA 510(k) Clearance for its Aspiration Catheters](https://www.vesalio.com/vesalio-expands-international-neurovascular-portfolio-with-ce-mark-of-neva-vs-and-neva-3-0-mm-and-receives-additional-fda-510k-clearance-for-its-aspiration-catheters/) - Company advances global neuro-intervention footprint with new CE-marked devices for vasospasm and stroke, and expanded U.S. indications for aspiration catheters. - [Vesalio Receives Two FDA 510(k) Clearances, Advancing Its Comprehensive Thrombectomy Platform with Aspiration Technology](https://www.vesalio.com/vesalio-receives-two-fda-510k-clearances-advancing-its-comprehensive-thrombectomy-platform-with-aspiration-technology/) - The FDA clearances expand Vesalio’s thrombectomy portfolio to support its growth strategy in the rapidly expanding multi-billion-dollar global thrombectomy market. - [Vesalio Receives FDA 510(k) Clearance of enVast, the First Stent-Based Coronary Thrombectomy Technology](https://www.vesalio.com/vesalio-receives-fda-510k-clearance-of-envast-the-first-stent-based-coronary-thrombectomy-technology/) - The FDA clearance of enVast redefines coronary thrombectomy treatment and further expands Vesalio’s commercial platform. - [ENVAST Intro Presentation](https://www.vesalio.com/new-envast-intro-presentation/) - To be used as an elevator pitch deck for initial enVast contacts. Taking too long? Reload document | Open in new tab Download [3.94 MB] - [READ FIRST - NeVa Training One Pager](https://www.vesalio.com/read-first-neva-training-one-pager/) - START HERE - Watch the recorded sessions and other training resources by clicking on the links in the document. - [05. NEW NEVA CLINICAL CASES PRESENTATION](https://www.vesalio.com/neva-clinical-cases-presentation/) - Neva and NeVa NET cases in a simple pdf format. Note that some of these cases are available in detail on NeVa Clinical Cases Page on the website. Contact Market Development for the PowerPoint version and for help in organizing a NeVa Induction Webinar if needed. - [03. LV-MKT-007 REV B NEVA CATH LAB POSTER A2](https://www.vesalio.com/vesalio-neva-a2-poster/) - A2 Poster Format designed to hang in Neuro Cath Labs as a quick reference - [06. NEVA CASE FEEDBACK FORM](https://www.vesalio.com/neva-case-feedback-form/) - Important follow up tool to share with newly initiated sites for collecting case feedback during evaluation phase. Can be used on an ongoing basis for collecting feedback in willing sites. - [04. NEW NEVA CUSTOMER PRESENTATION](https://www.vesalio.com/neva-customer-presentation/) - Includes design goals, features and benefits, clinical evidence, tips & tricks on how to maximize the Drop Zone impact. Contact Market Development for the PowerPoint version and for help in organizing a NeVa Induction Webinar if needed. - [01. NEVA & NEVA NET SPECIFICATIONS SHEET](https://www.vesalio.com/neva-specifications-sheet/) - To be used for tenders as needed. - [01. Anatomy](https://www.vesalio.com/anatomy/) - VESALIO BASIC TRAINING Module 1: Introduction to Neurovascular Anatomy - [02. Cath Lab](https://www.vesalio.com/cath-lab/) - VESALIO BASIC TRAINING Module 2: Introduction to the Angio Suite (or Cath Lab) - [NeVa VS Training Presentation](https://www.vesalio.com/neva-vs-training-presentation/) - Taking too long? Reload document | Open in new tab Download [2.65 MB] - [READ FIRST - NeVa VS Training One Pager](https://www.vesalio.com/neva-vs-training-one-pager/) - START HERE - Watch the recorded sessions and other training resources by clicking on the links in the document. - [NeVa VS Feedback Form](https://www.vesalio.com/neva-vs-feedback-form/) - Form to share with newly initiated sites for collecting case feedback during evaluation phase. Can be used on an ongoing basis for collecting feedback in willing sites. - [NeVa VS Cath Lab Poster](https://www.vesalio.com/neva-vs-cath-lab-poster/) - A3 Poster Format designed to hang in Neuro Cath Labs as a quick reference. - [NeVa VS Cases Presentation](https://www.vesalio.com/neva-vs-cases-presentation/) - NeVa VS cases in a simple pdf format. Note that some of these cases are available in detail on NeVa VS Clinical Cases Page on the website. - [NeVa VS Customer Presentation](https://www.vesalio.com/neva-vs-customer-presentation/) - Includes design, features and benefits, clinical evidence, tips & tricks on how to maximize device impact. Contact Market Development for the PowerPoint version and for help if needed. - [NeVa VS Spec Sheet](https://www.vesalio.com/neva-vs-spec-sheet/) - To be used for tenders as needed. - [NeVa VS Brochure](https://www.vesalio.com/neva-vs-brochure/) - Product brochure to be used as leave behind piece as needed. - [NEW ENVAST PROCEDURE CARDS](https://www.vesalio.com/envast-procedure-cards/) - Procedure cards to support physicians during procedures. Contact Vesalio Marketing for printing. - [NEW ENVAST Specifications Sheet](https://www.vesalio.com/envast-specifications-sheet/) - To be used for tenders as needed. Taking too long? Reload document | Open in new tab Download [108.70 KB] - [READ FIRST – enVast Training One Pager](https://www.vesalio.com/read-first-envast-training-one-pager/) - START HERE – Review this PDF before starting on any training modules - [Expansion of International Distributor Network and Stroke Congress Exhibition Presence](https://www.vesalio.com/expansion-of-international-distributor-network-and-stroke-congress-exhibition-presence/) - Vesalio announces it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market coverage in 39 countries for the NeVa™ Neuro-thrombectomy System. - [Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions](https://www.vesalio.com/vesalio-launches-pvasc-thrombectomy-system-in-the-u-s-for-peripheral-occlusions/) - Introducing pVasc™ mechanical thrombectomy system for the safe and effective non-surgical removal of occlusions from the peripheral vasculature - [VESALIO Introduces NeVa NET 4.0 mm Following International Success of NeVa NET 5.5 mm](https://www.vesalio.com/vesalio-introduces-neva-net-4-0-mm-following-international-success-of-neva-net-5-5-mm/) - Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology. - [Vesalio appoints CFO and announces company headquarters in Dallas, Texas](https://www.vesalio.com/vesalio-appoints-cfo-and-announces-company-headquarters-in-dallas-texas/) - Introducing pVasc™ mechanical thrombectomy system for the safe and effective non-surgical removal of occlusions from the peripheral vasculature - [NeVa CLEAR Study results presented at ESMINT: innovative thrombectomy device achieves notable first-pass success and patient outcomes](https://www.vesalio.com/neva-clear-study-results-presented-at-esmint/) - Primary results from the CLEAR Study were presented at the ESMINT annual meeting in Marseille, France (4-6 September 2023), where Vesalio also announced the fifth anniversary of the international commercialization of the NeVa™ device. - [Vesalio Announces Initial Use of its Uniquely Designed and FDA-approved NeVa VS Device](https://www.vesalio.com/vesalio-announces-initial-use-of-fda-approved-neva-vs-device/) - Vesalio Introduces pVasc™ U.S. Clinical Study to capture real-world data and optimize results for patients suffering from peripheral vascular disease. - [Vesalio appoints VP of U.S. Sales and announces recent publication on NeVa showing impressive first pass rates](https://www.vesalio.com/vesalio-appoints-vp-of-us-sales/) - Vesalio hires Bob Bushok as VP of U.S. Sales and announces high first-pass rates and favorable safety profile in a 145-stroke patient data set for the NeVa™ thrombectomy device with findings published in the journal Interventional Neuroradiology. - [Vesalio announces EU MDR Certification](https://www.vesalio.com/vesalio-announces-eu-mdr-certification/) - MDR certification confirms the company’s commitment of ensuring that their innovative new products meet or exceed these rigorous new standards. - [Vesalio announces FDA Approval of the NeVa VS™](https://www.vesalio.com/vesalio-announces-fda-approval-of-the-neva-vs/) - NeVa VS is a patented retrievable nitinol stent specifically designed to treat cerebral vasospasm after aneurysmal rupture. - [Vesalio announces CE Approval for new NeVa NET™](https://www.vesalio.com/vesalio-announces-ce-approval-for-new-neva-net/) - The first integrated clot micro-filtration technology for stroke thrombectomy patients. - [Vesalio announces oversubscribed Class A financing](https://www.vesalio.com/vesalio-announces-oversubscribed-class-a-financing/) - Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round. - [Vesalio Announces Completion of Enrollment in its FDA Enabling Stroke Study](https://www.vesalio.com/vesalio-announces-completion-of-enrollment-in-its-fda-enabling-stroke-study/) - Vesalio announces the completion of enrollment in its FDA IDE clinical study for acute ischemic stroke. - [Vesalio Announces Earl Slee as New Board Observer and Senior Advisor to the Company](https://www.vesalio.com/vesalio-announces-earl-slee-as-new-board-observer-and-senior-advisor-to-the-company/) - As a board observer and senior advisor to the company, Earl Slee brings extensive medical device innovation and business development expertise. - [Vesalio Announces Appointment of Mike Kujak as its New Independent Board Chairman](https://www.vesalio.com/vesalio-announces-appointment-of-mike-kujak-as-its-new-independent-board-chairman/) - As an independent board chairman, Mike Kujak will bring expert knowledge and know-how from his years of leadership in the medical device start-up space. - [Vesalio Initiates Clinical Study Evaluating Innovative Thrombectomy Technique for Patients with STEMI](https://www.vesalio.com/vesalio-initiates-clinical-study-evaluating-innovative-thrombectomy-technique-for-patients-with-stemi/) - Vesalio announced the start of enrollment in its NATURE study using enVast™, the company’s first thrombectomy system for patients presenting with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention. - [Vesalio Secures Class A Funding](https://www.vesalio.com/vesalio-secures-class-a-funding/) - Vesalio announces it has successfully secured a Class A financing round. The proceeds will be utilized to support the ongoing US IDE stroke study, establish US infrastructure, expand its innovative product portfolio, and scale international business. - [Vesalio Initiates FDA IDE Stroke Study](https://www.vesalio.com/vesalio-initiates-fda-ide-stroke-study/) - Vesalio announces another key milestone to support entry into the US neurovascular thrombectomy market. Enrollment has commenced in the Vesalio CLEAR acute ischemic stroke FDA IDE clinical trial utilizing the NeVaTM thrombectomy technology platform. - [Vesalio Announces Launch of pVasc Study in the U.S. While Featuring the pVasc Thrombectomy System at VIVA, VEITH, and TCT](https://www.vesalio.com/vesalio-announces-launch-of-pvasc-study-in-the-u-s-while-featuring-the-pvasc-thrombectomy-system-at-viva-veith-and-tct/) - Vesalio Introduces pVasc™ U.S. Clinical Study to capture real-world data and optimize results for patients suffering from peripheral vascular disease. - [ENVAST ROLL UP BANNERS](https://www.vesalio.com/envast-roll-up-banners/) - PDF to download for printing of roll up banners to use at local meetings and events - [ENVAST BROCHURE](https://www.vesalio.com/envast-brochure/) - Download Print Ready Version: enVast Brochure | Download Digital Version: High Resolution enVast Brochure Product brochure to be used as leave behind piece as needed. Please follow ENVAST BRANDING GUIDELINES if local adaptation is needed. Taking too long? Reload document | Open in new tab Download [4.19 MB] - [EVT Article](https://www.vesalio.com/evt-article/) - Taking too long? Reload document | Open in new tab Download [6.16 MB] - [pVasc Training Module 5: pVasc Physician Presentation](https://www.vesalio.com/pvasc-training-pvasc-selling/) - Become confident articulating pVasc’s messaging and how pVasc fits into a physician’s practice - [NEW ENVAST Procedure Presentation](https://www.vesalio.com/envast-procedure-presentation/) - To be used for training physicians on the procedure steps. Contact Market Development to obtain the powerpoint version, getting training, or to organize an enVast training session with your customer. Taking too long? Reload document | Open in new tab Download [4.27 MB] - [ENVAST Cath-Lab Staff Presentation](https://www.vesalio.com/envast-cath-lab-staff-presentation/) - To be used for presentations to the cath lab staff before enVast use is initiated at a site. Contact Market Development for help if needed. Download Link: Click Here Taking too long? Reload document | Open in new tab Download [2.88 MB] - [NEW ENVAST PROCEDURE GUIDE](https://www.vesalio.com/envast-procedure-guide-poster-format/) - enVast Procedure Guide – Two Formats Available To support physicians during procedures, the enVast Procedure Guide is available in two easy-to-use formats: A2 Poster Format Download here: enVast A2 Poster A4 Handout Format Download here: enVast A4 Handout Both versions can be downloaded, printed, and shared. Please follow VESALIO BRANDING GUIDELINES for - [Procedure Poster](https://www.vesalio.com/pvasc-procedure-poster/) - Pocket guide to be shared with newly initiated sites and/or existing customers as a leave behind piece. Contact Market Development for help in organizing a pVasc Induction Webinar with your customer if needed. - [Physician Presentation](https://www.vesalio.com/pvasc-physician-presentation-with-cases/) - Used for introducing pVasc – its benefits and positive case experience – to customers. This presentation can also be shared with customers to create their own talks at local meetings or conferences. - [In-Service Presentation](https://www.vesalio.com/pvasc-inservice-presentation/) - To be used for training or inservicing with customers. Modular: different sections can be used as needed. Contact Market Development for help in obtaining the PowerPoint file, getting training, or organizing a pVasc Induction Webinar with your customer as needed. - [READ FIRST - pVasc Training One Pager](https://www.vesalio.com/pvasc-training-one-pager/) - START HERE - Review this PDF before starting on any training modules - [pVasc Training Module 2: In-Service](https://www.vesalio.com/pvasc-training-physician-presentation/) - Familiarize yourself with the pVasc design and its basic use recommendations - [pVasc Training Module 1: Anatomy & Disease State](https://www.vesalio.com/pvasc-training-anatomy-and-disease-state/) - Learn the arterial anatomy of the lower extremity and SMA. Review PAD and the role for pVasc - [pVasc Training Module 6: Clinical Evidence](https://www.vesalio.com/pvasc-training-clinical-evidence/) - Develop a high level understanding of the most recent clinical study for ALI -- Penumbra’s STRIDE study - [pVasc Case Feedback Form](https://www.vesalio.com/pvasc-case-feedback-form/) - Important follow-up tool to share with newly initiated sites for collecting case feedback during evaluation phases. Can be used on an ongoing basis at sites that are willing. - [pVasc Brochure](https://www.vesalio.com/pvasc-brochure/) - Product brochure to be used as leave behind piece as needed. - [pVasc Procedure Guide](https://www.vesalio.com/pvasc-procedure-guide/) - Pocket guide to be shared with newly initiated sites and/or existing customers as a leave behind piece. Contact Market Development for help in organizing a pVasc Induction Webinar with your customer if needed. - [pVasc Roll Up Banners](https://www.vesalio.com/pvasc-roll-up-banners/) - PDFs to download and print as roll-up banners to use at local meetings and events. - [pVasc Print Ad](https://www.vesalio.com/pvasc-print-ad/) - PDF to download and share with print media. No changes are allowed. - [pVasc Training Module 3: pVasc Procedure](https://www.vesalio.com/pvasc-training-pvasc-procedure/) - Become proficient with the pVasc procedure, including best practices - [pVasc Training Module 4: Competition](https://www.vesalio.com/pvasc-training-pvasc-competition/) - Review of competitive products, their positioning and their strengths/weaknesses - [Vesalio Field Report](https://www.vesalio.com/vesalio-field-report-2/) - Report template for case feedback. Can also be used for complaints reporting. Taking too long? Reload document | Open in new tab Download [165.09 KB] - [Vesalio Field Report](https://www.vesalio.com/vesalio-field-report/) - Report template for case feedback. Can also be used for complaints reporting. Taking too long? Reload document | Open in new tab Download [165.09 KB] - [Another Successful Vesalio™ Clot Interaction Workshop in Barcelona](https://www.vesalio.com/another-successful-vesalio-clot-interaction-workshop-in-barcelona/) - On January 22 and 23, a diverse group of physicians from 8 different countries trained on new approaches for clot retrieval with the NeVa™ Drop Zone Retrieval Technique at the Vesalio Clot Interaction Workshops that took place at the Vall d’Hebron Research Institute. - [Vesalio Reports 2,500 Patient Milestone](https://www.vesalio.com/vesalio-reports-2500-patient-milestone/) - Vesalio reports it has surpassed 2,500 clinical cases with the NeVa™ neuro-thrombectomy platform. Physicians have evaluated the Neva Drop Zone™ technology with enthusiasm as it has shown a unique capability of removing the full spectrum of clot types in large vessel occlusion ischemic stroke. - [NeVa: More & More are Training to #DoTheDropZone](https://www.vesalio.com/neva-more-and-more-are-training-to-dothedropzone/) - A growing number of European & Middle Eastern doctors and stroke teams are training to #DoTheDropZone with NeVa, a revolutionary thrombectomy device with high first pass rates. - [enVast First-In-Human One Pager](https://www.vesalio.com/envast-first-in-human-one-pager/) - [ENVAST CASE FEEDBACK FORM](https://www.vesalio.com/envast-case-feedback-form/) - Important follow up tool to share with newly initiated sites for collecting case feedback during evaluation phase. Can be used on an ongoing basis for collecting feedback in willing sites. Taking too long? Reload document | Open in new tab Download [18.70 MB] - [Vesalio Reports Expansion of Commercial Distribution, Additional Published Data on the NeVa™ System](https://www.vesalio.com/vesalio-reports-expansion-of-commercial-distribution-additional-published-data-on-the-neva-system/) - Vesalio announces it has executed multiple exclusive distribution agreements in Europe and now has market coverage in 25 countries for the NeVa Neurothrombectomy System. - [Positive Results in Early NeVa™ Human Thrombectomy Procedures](https://www.vesalio.com/positive-results-in-early-neva-human-thrombectomy-procedures/) - Vesalio announces it has completed European enrollment of the first twenty-five human cases in a post-market registry of the proprietary NeVa™ neurothrombectomy platform for the treatment of stroke. - [NeVa™ Drop Zone Effect - Initial Experience Presented at ABC Win](https://www.vesalio.com/neva-drop-zone-effect-initial-experience-presented-at-abc-win/) - On January 18, 2019, Professor Serdar Geyik (Istanbul Istinye University) presented his early NeVa experience at the ABC-WIN Seminar in Val D’Isere, France. - [Vesalio Initiates Full Commercial Launch of NeVa at the 10th Anniversary of ESMINT](https://www.vesalio.com/vesalio-initiates-full-commercial-launch-of-neva-at-the-10th-anniversary-of-esmint/) - Vesalio announces it has initiated the full commercial European launch of its NeVa neurothrombectomy platform at the 10th annual congress of the European Society of Minimally Invasive Neurological Therapy. - [Vesalio Announces NeVa™ Stroke Treatment Product CE Mark Certification](https://www.vesalio.com/vesalio-announces-neva-stroke-treatment-product-ce-mark-certification/) - Vesalio announces the CE Mark certification of its first product line, the proprietary NeVa™ neurothrombectomy platform for the treatment of stroke. - [Vesalio and Vassa Medical celebrate NeVa™ Launch in Mirano, Italy](https://www.vesalio.com/on-april-5th-the-vassa-medical-national-sales-network-convened-to-celebrate-the-italy-launch-of-neva-at-the-companys-headquarters-in-mirano-near-venice-dr-massimo-sponza-from-udine-hospit/) - On April 5th, the Vassa Medical national sales network convened to celebrate the Italy launch of NeVa at the company’s headquarters in Mirano near Venice. Dr. Massimo Sponza from Udine Hospital was present to train the team on acute ischemic stroke and thrombectomy. - [NeVa™ First Clinical Experience Data Presented at the International Stroke Conference](https://www.vesalio.com/neva-first-clinical-experience-data-presented-at-the-international-stroke-conference/) - From Val D’Isere, France to Honolulu, Vesalio’s early clinical experience data is being presented globally. - [EnVast](https://www.vesalio.com/envast/) - NeVa captures clots inside & retains fragments - [Neva VS](https://www.vesalio.com/neva-vs/) - Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis quis accumsan felis. Fusce quam nibh, porttitor et fermentum ut, congue quis sem. Aenean vitae dui nec enim blandit faucibus. Vivamus posuere hendrerit diam sit amet dapibus. Mauris finibus elit neque. Curabitur nec malesuada dui. - [Neva](https://www.vesalio.com/consectetur-adipiscing-elit-duis-quis/) - Lorem ipsum dolor sit amet, consectetur adipiscing elit. Duis quis accumsan felis. Fusce quam nibh, porttitor et fermentum ut, congue quis sem. Aenean vitae dui nec enim blandit faucibus. Vivamus posuere hendrerit diam sit amet dapibus. Mauris finibus elit neque. Curabitur nec malesuada dui. - [VESALIO ENVAST BRANDING RESOURCES](https://www.vesalio.com/vesalio-envast-branding-resources/) - Brand guidelines to show the Vesalio brand is to be used and presented to the public. - [Vesalio Neva Branding Resources](https://www.vesalio.com/vesalio-neva-branding-resources/) - Brand guidelines to show the Vesalio brand is to be used and presented to the public. - [ENVAST A4 PRINT AD](https://www.vesalio.com/envast-ad/) - PDF to download and share with print media. No changes are allowed. Taking too long? Reload document | Open in new tab Download [451.93 KB] - [Vesalio Micro Flow Model IFU](https://www.vesalio.com/vesalio-micro-flow-model-ifu/) - Flow model set up and breakdown pdf for viewing. - [Vesalio™ Secures $5 Million Investment Capital Funding](https://www.vesalio.com/vesalio-secures-5-million-investment-capital-funding/) - Vesalio announces it has recently raised $5 million in funding. The capital will support the continued global expansion of the NeVa™ Neurothrombectomy System, finance key clinical studies and launch new product introductions. - [Vesalio Obtains Additional CE Approval for New Products, NeVa™ Clinical Data Published](https://www.vesalio.com/vesalio-obtains-additional-ce-approval-for-new-products-neva-clinical-data-published/) - Vesalio announces it has obtained its second CE Approval spanning multiple new NeVa™ product designs and technology. The new generation NeVa devices expand on the Drop Zone™ and Smart Marker™ technologies. - [Initiates Virtual Training and Announces Pass Effect Rate Publication](https://www.vesalio.com/initiates-virtual-training-and-announces-pass-effect-rate-publication/) - Vesalio announces it has executed additional exclusive distribution agreements in Europe, Latin America, Asia, and the Middle East. With these new partnerships, the NeVa™ Thrombectomy System has gained market coverage in 53 countries. - [Vesalio Receives Peripheral FDA 510k Clearance and Additional CE Approval](https://www.vesalio.com/vesalio-receives-peripheral-fda-510k-clearance-and-additional-ce-approval/) - Vesalio reports it has obtained an FDA 510k clearance and its 4th CE approval. The FDA 510k indication is for the removal of thrombi in peripheral blood vessels. - [Vesalio Attains Key FDA Clinical Study Milestone](https://www.vesalio.com/vesalio-attains-key-fda-clinical-study-milestone/) - Vesalio announces it has accomplished a key FDA IDE study milestone to support entry into the US neurovascular market. Enrollment in the VITAL 1 clinical trial, assessing the company’s NeVa VS™ technology in the treatment of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage (aSAH), has been completed. - [VESALIO Mood: Elated, Excited and Ready to Rock in 2020](https://www.vesalio.com/vesalio-mood-elated-excited-and-ready-to-rock-in-2020/) - As the end of 2019 approaches, we reflect with pride and gratitude on what we achieved: We saw the publication of our First in Man data and initiated our regulatory enabling studies, We received our 2nd CE mark on the expanded #NeVa platform, including designs with more Drop Zones, We organized 5 Vesalio Clot ## Pages - [Home](https://www.vesalio.com/) - Vesalio is dedicated to advancing care of patients suffering from vascular occlusion by providing physicians technology designed to improve clinical outcomes. - [enVast Publications](https://www.vesalio.com/envast-publications/) - enVast PUBLICATIONS Featured PUBLICATION ENVAST FIRST-IN-HUMAN First experience with the enVast device in 61 STEMI patients with large clot burden. Alessandro Spirito, MD; Angelo Quagliana, MD; Marco Coiro, MD; Gebremedhin D. Melaku, MD; Stijn Vandenberghe, MD; Gregor Leibundgut, MD, PhD; Jonas Häner, MD; Marco Moccetti, MD; Marco Araco, MD; Hector M. Garcia-Garcia, MD; Marco Valgimigli - [NeVa VS Publications](https://www.vesalio.com/neva-vs-publications/) - NeVa VS PUBLICATIONS FeaturedPUBLICATION CLEAR: a prospective multicenter IDE study Primary results from the CLEAR study of a novel stent retriever with drop zone technology Albert J Yoo, Serdar Geyik, Michael T Froehler, Christoph Johannes Maurer, Tareq Kass-Hout, Osama O Zaidat, Raul G Nogueira, Ricardo A Hanel, Laurent Pierot, Laurent Spelle, Demetrius Lopes, Ameer Hassan, - [NeVa Publications](https://www.vesalio.com/neva-publications/) - NeVa PUBLICATIONS FeaturedPUBLICATION CLEAR: a prospective multicenter IDE study Yoo AJ, Geyik S, Froehler MT, et al. Primary results from the CLEAR study of a novel stent retriever with drop zone technology Journal of Neuro-Interventional Surgery 2024 READ PUBLICATION > NEVA: 39-PATIENT BAILOUT EXPERIENCE Fairhead R, Mancuso-Marcello M, Ahmed R, et al. The use of - [Pre-Clinical Study in Swine](https://www.vesalio.com/neva-publications/pre-clinical-study/) - PRE-CLINICAL STUDY IN SWINE Paper: Preclinical Evaluation of the NeVa™ Stent Retriever: Safety and Efficacy in the Swine Thrombectomy Model Authors: Ulm, Kachatryan, Grigorian, Nogeira Journal: INTERVENTIONAL NEUROLOGY, FEB 13, 2018 Background and Purpose: NeVa stent retriever has been developed with an enhanced radial force profile, enlarged offset openings, and a closed distal end. The - [Vesalio Leadership Team | Vesalio Executive Team](https://www.vesalio.com/about/leadership-team/) - Led by CEO Steve Rybka, Vesalio's Leadership Team drives our mission to change lives by making advances in stroke treatment & clot capture. - [Discover pVasc](https://www.vesalio.com/technology/discover-pvasc/) - Discover pVascTM WHEN COMPLEXITY REQUIRES Simplicity The pVasc™ Thrombectomy System is designed to remove thromboembolism from the peripheral arterial vasculature quickly and reliably with simplicity. Frank Arko, MD Charlotte, NC “Given the complicated health history of patients with ALI, physicians often face the challenge of delivering devices through highly diseased arteries and working in small, - [Discover NeVasc](https://www.vesalio.com/technology/discover-nevasc/) - *This product is FDA approved, but not CE marked DISCOVER NEVASC ASPIRATION CATHETER NeVasc is created for speed and performance 10 TRANSITION ZONES Provide variable flexibility for exceptional tracking STAINLESS STEEL COIL CONSTRUCTION optimizes distal flexibility for navigating tortuosity BRAIDED, COIL-REINFORCED CONSTRUCTION Optimizes pushability and kink-resistance HYDROPHILIC COATING Aids smooth delivery Link to IFU Contact - [NeVasc Instructions for Use](https://www.vesalio.com/nevasc-ifu-fda/) - NeVasc Instructions for Use Indications, Safety, and Warnings Federal law (USA) restricts this device to sale by or on the order of a physician. Indication for Use The NeVasc Aspiration Catheter, with the Vesalio Aspiration Tubing Set and a compatible suction pump is indicated for use in the revascularization of patients with acute ischemic stroke - [Discover enVast](https://www.vesalio.com/technology/discover-envast/) - Discover enVastTM ENGINEERED FOR CORONARY THROMBECTOMY enVast is the first and only CE-approved and FDA-cleared large thrombus burden retriever in patients with coronary occlusions. LINK TO IFU LINK TO IFU ENVAST EFFECTIVE & SAFE Equipped with Drop Zone technology, the enVast coronary thrombectomy system has been proven to remove large thrombus burden (LTB) and create immediate reperfusion - [enVast Instructions for Use](https://www.vesalio.com/envast-ifu-fda/) - enVast Instructions for Use Indication for Use The enVast Thrombectomy Device is indicated for: The non-surgical removal of thrombus burden from coronary blood vessels, Use with adjunctive aspiration and with the injection or infusion of contrast media and other fluids. CAUTION: Evaluate the risks associated with coronary vascular interventional therapy (see complications below) and the - [Discover NeVa VS](https://www.vesalio.com/technology/discover-neva-vs/) - DISCOVER neva vs A DEFINITIVE SOLUTION for post aSAH Vasospasm NEVA VS, SPECIFIC TO VASOSPASM TREATMENT NeVa VS combines a smooth and continuous architecture and the deliverability of a stent retriever with an enhanced outward radial force to effectively dilate critically narrowed vessels. CEREBRAL VASOSPASM COMMON AND DEADLY 1 in 10,000 people experience an aneurysm - [enVast Instructions for Use](https://www.vesalio.com/envast-ifu-ce/) - enVast Instructions for Use Indication for Use The Vesalio enVast Mechanical Thrombectomy System is indicated for endovascular temporary use to restore blood flow in patients who are experiencing symptoms of thrombosis in the coronary vasculature. CONTRAINDICATIONS Delivery of pharmacological agents not routinely used to treat thrombosis in the coronary vasculature Patient presents with nickel allergy - [NeVa VS Int'l Instructions for Use](https://www.vesalio.com/nevavs-ifu-ce/) - NeVa VS Instructions for Use Indications, Safety, and Warnings Indication for Use The Vesalio NeVa VS is indicated for: Endovascular temporary use in patients with acute ischemic stroke Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of an acute ischemic stroke caused by an embolus in a cerebral vessel Endovascular - [Discover NeVa Net](https://www.vesalio.com/technology/discover-neva-net/) - DISCOVER NEVA NET THE NEXT FRONTIER IN THROMBECTOMY IN THE BACK OF THE NET:INSIGHTS ON THE LATEST NEVA TECHNOLOGY Watch this ESMINT STUIDIO Session where Prof Wim van Zwam, Dr. Paul Bhogal and Dr. Roland Schwab discuss why NeVa and NeVa NET are making headlines in the stroke world. Click to view video. THE WORLD’S - [Discover NeVa](https://www.vesalio.com/technology/discover-neva/) - Discover NeVa FIRST PASS SUCCESS WITH ALL CLOT TYPES Unique proprietaryDrop Zonetechnology Effective superior 1st Passrecanalization rates Consistent efficiencyacross ALLclot types drop zone technology​ In action DOING THE DROP ZONEAT SLICE Watch this extract from the SLICE INSIDE Episode 2: AGAINST THE CLOCK where NeVa does what it does best in a single pass in - [NeVa & NeVa Net Instructions for Use](https://www.vesalio.com/neva-ifu-ce/) - NeVa & NeVa Net Instructions for Use Indications, Safety, and Warnings Indication for Use The Vesalio NeVa & NeVa Net Mechanical Thrombectomy System is indicated for: Endovascular temporary use in patients with acute ischemic stroke Endovascular temporary use to restore blood flow in patients who are experiencing symptoms of an acute ischemic stroke caused by - [Careers](https://www.vesalio.com/about/careers/) - CAREERS AT VESALIO A career with Vesaliois more than just a job It is becoming part of a fast-moving, adventurous team that cares deeply about human life and is committed to saving and improving lives through advancing standards of care in exciting fields such as interventional neuro-radiology and cardiology. See Open Positions We LOOK FOR - [NeVa VS Clinical Cases](https://www.vesalio.com/neva-vs-clinical-cases/) - NeVa VS CLINICAL CASES LINNC SEMINAR Cerebral Vasospasm – RECORDED CASE PRESENTATION Charles Matouk, MD FRCC (C), Vice Chair (Clinical Affairs), Chief of Neurovascular Surgery Director, NPH Program Department of Neurosurgery, Yale University School of Medicine Dr. Santiago Ortega – Gutierrez, MD, MSc, FAHA, FSVIN, Professor of Neurology, Neurosurgery or Radiology, President of the Society - [Clinical](https://www.vesalio.com/clinical/) - VESALIO CLINICAL Clinical publications & case studies on Vesalio product lines Read on to find out about the clinical performance of NeVa and NeVa VS in neurothrombectomy and post-aSAH vasospasm treatment. Read on to find out about the clinical performance of NeVa, NeVa VS, and enVast in neurothrombectomy, post-aSAH vasospasm treatment, and coronary thrombectomy respectively. - [Customer Service/Sales Support Representative](https://www.vesalio.com/about/careers/customer-service-sales-support-representative/) - Customer Service/Sales Support Representative Department: U.S. Commercial Reports To: CCO or VP of Sales POSITION DESCRIPTION: The Customer Service/Sales Support Representative plays a vital role in supporting healthcare providers and our sales teams by ensuring seamless communication, accurate order management, and timely resolution of inquiries. This position serves as the frontline connection between our company, - [News](https://www.vesalio.com/news/) - News View allBlog ArticlesPress Releases Vesalio Announces Late-Breaking Clinical Trial Presentation of the enVast NATURE Study at the ESC Congress 2026 Press ReleasesJuly 21, 2026 NATURE trial, a prospective randomized controlled trial comparing the safety and effectiveness of thrombectomy using enVast before conventional PCI versus standard of care alone, was selected for the prestigious Late-Breaking - [Resources](https://www.vesalio.com/resources/) - Resources Access Resources NeVa NeVa VS enVast pVasc - [NeVa Clinical Cases](https://www.vesalio.com/clinical-cases/) - NeVa CLINICAL CASES EXTRACT FROM SLICE INSIDE EPISODE 2: AGAINST THE CLOCK featuring NeVa 4.5 x 29 mm Dr. Grégory GascouMontpellier University Hospital Gui de Chauliac, Montpellier, France WATCH CASE EXTRACT > ONE-PASS RESCUE IN A CAROTID OCCLUSION INVOLVING P-COM & AChA NeVa™ 5.5 x 37 mm Dr. med. Christian CommodaroMedico Capoclinica, INR Unit, Lugano, - [Technology](https://www.vesalio.com/technology/) - Taking Clot Capture to the Next Level With Drop Zone Technology Multiple passes Engineered into one Drop Zones dynamically change clot interaction by capturing thrombi inside the device instead of relying on penetration of clot and subsequent pin and drag along the artery wall. Each Drop Zone provides an additional opportunity to secure clot during - [Discover NeVa 3mm](https://www.vesalio.com/technology/discover-neva-3mm/) - Discover NeVa 3mm *This product is CE marked, but not FDA approved DROP ZONE TECHNOLOGY™ REACHING NEW ANATOMY Extending the reach of Vesalio’s proven Drop Zone™ technology engineered for All Clot Types For arteries as small as 1.5 mmPerfect for M2, ACA & PCA occlusions Radial force attuned to delicate anatomy A seamless, continuous structure - [Extract From SLICE INSIDE Episode 2: Race Against the Clock](https://www.vesalio.com/clinical-cases/neva-case-20-gascou1-extract-from-slice/) - EXTRACT FROM SLICE INSIDE EPISODE 2: AGAINST THE CLOCK NeVa™ (4.5 x 29 mm) An extract from SLICE INSIDE Episode 2: AGAINST THE CLOCK – featuring the use of Vesalio NeVa thrombectomy device in an MCA occlusion. Chapters 00:00 Intro00:18 Patient Presentation01:08 Intracranial Access02:37 Roadmap & Access to MCA-M103:37 First MCA pass with NeVa™06:25 The - [Sales Manager – Germany Direct Business](https://www.vesalio.com/about/careers/sales-manager-germany-direct-business/) - Sales Manager – Germany Direct Business Department: International Business Reports To: Hans Bruns, PhD Supervisory Responsibilities: N/A POSITION DESCRIPTION: Drive sales & market share growth of Vesalio endovascular products in designated hospital accounts in Germany drawing upon proven neurovascular, cardiovascular and peripheral thrombectomy sales experience & exceptional territory and account management skills. Objective: Achieve strategic - [Product Manager – Coronary](https://www.vesalio.com/about/careers/product-manager-coronary/) - Product Manager – Coronary Department: Marketing & Market Development Reports To: VP Market Development and U.S. Marketing Lead Supervisory Responsibilities: N/A POSITION DESCRIPTION: Under the direction of the VP of Market Development and the U.S. Marketing lead, the Product Manager (PM) will play a crucial role in driving both upstream and downstream marketing of the - [NEVA: 39-PATIENT BAILOUT EXPERIENCE](https://www.vesalio.com/neva-publications/neva-39-patient-bailout-experience/) - NEVA: 39-PATIENT BAILOUT EXPERIENCE Paper: The use of the NeVa stent-retriever for bail-out mechanical thrombectomy Authors: Rory Fairhead, Marco Mancuso-Marcello, Rafee Ahmed, Keng Siang Lee, Christos Nikola, Katherine Parkin, Giovanna Klefti, Levansri Makalanda, Ken Wong, Joe Lansley, Michael Przyszlak, Oliver Spooner, Pervinder Bhogal Journal: Interventional Neuroradiology – SEPT 2025 Background: Mechanical thrombectomy (MT) has become - [One-Pass Rescue In A Carotid Occlusion Involving P-Com & AChA](https://www.vesalio.com/clinical-cases/neva-case-19-commodaro1-1stpassrescue-ica-pcom-acha/) - ONE-PASS RESCUE IN A CAROTID OCCLUSION INVOLVING P-COM & AChA NeVa™ 5.5 x 37 mm Dr. med. Christian CommodaroMedico Capoclinica, INR Unit, Lugano, Switzerland Clinical Case Report Presentation A 55-year-old male patient with a mechanical heart valve presented with a fluctuating NIHSS ranging from 3 to 11. Dr. med. Christian CommodaroMedico Capoclinica, INR UnitLugano, Switzerland - [About](https://www.vesalio.com/about/) - INNOVATING TO MEET THE CHALLENGES OF ENDOVASCULAR INTERVENTION We Are Vesalio Learn more about us through the voices of our partners, physicians, and employees as they share what we do best, how we’ve evolved, and where we are headed… CHANGING OUTCOMES CHANGING LIVES VESALIO is dedicated to advancing the care of patients suffering from vascular - [NeVa Case 12 Geyik4 NeVa in I Type Occlusion with Surprises](https://www.vesalio.com/clinical-cases/neva-case-12-geyik4-neva-in-i-type-occlusion-with-surprises/) - NeVa Thrombectomy in an I-type ICA Occlusion presenting with basilar stroke symptoms: Case broadcast live at iCureStroke 2022 with Prof Geyik & Dr Bajrami - [NEVA NET 4.0 FIRST CLINICAL MULTICENTER EXPERIENCE](https://www.vesalio.com/neva-publications/neva-net-4-0-first-clinical-multicenter-experience/) - NEVA NET 4.0 FIRST CLINICAL MULTICENTER EXPERIENCE Paper: The NeVa Net stent-retriever – initial report of 20 cases from two high volume centres Authors: Pervinder Bhogal, Marco Mancuso-Marcello, Rory Fairhead, Nadia Shah, Keng Siang Lee, Christos Nikola, Katherine Parkin, Giovanna Klefti, Levansri Makalanda, Ken Wong, Joe Lansley, Michael Przyszlak, Oliver Spooner, Branimir Čulo, Vladimir Kalousek - [The safety and efficacy of NeVa mechanical thrombectomy device in acute ischemic stroke](https://www.vesalio.com/neva-publications/the-safety-and-efficacy-of-neva-mechanical-thrombectomy-device-in-acute-ischemic-stroke/) - NEVA: A SYSTEMATIC REVIEW Paper: The safety and efficacy of NeVa mechanical thrombectomy device in acute ischemic stroke: A systematic review and meta-analysis Authors: Mohammad Amin Habibi, Mohammad Sina Mirjnani, Saeed Kargar-Soleimanabad, Mohammad Taha Akbari Javar, Maryam Diyanati, Muhammad Hussain Ahmadvand, Inka K. Berglarf, Adam A. Dmytriw Journal: Journal of Clinical Neuroscience 2024 Background: Recent - [Evaluation of efectiveness and safety of the multizone NeVa](https://www.vesalio.com/neva-publications/evaluation-of-effectiveness-and-safety-of-the-multizone-neva/) - NEVA: FIRST-LINE & BAILOUT EXPERIENCE Paper: Evaluation of effectiveness and safety of the multizone NeVa™ stent retriever for mechanical thrombectomy in ischemic stroke Authors: Max Masthoff, Hermann Krähling, Burak Han Akkurt, Mohamed Elsharkawy, Michael Köhler, Mostafa Ergawy, Christian Thomas, Wolfram Schwindt, Jens Minnerup, Paul Stracke Journal: INTERVENTIONAL NEURORADIOLOGY 2023 Purpose: This study aimed to evaluate - [Board of Directors](https://www.vesalio.com/about/board-of-directors/) - Vesalio's Board of Directors, lead by Board Chair, Mike Kujak, brings diverse skills & medical expertise, paramount to promoting the company's business success. - [Acute Stroke Treated with the NeVa](https://www.vesalio.com/neva-publications/acute-stroke-treated-with-the-neva/) - Neva: A 75-Patient Single Center Experience Paper: Immediate and 90-Day Clinical Outcome of Patients with Acute Stroke Treated with the NeVa-Vesalio Mechanical Thrombectomy Device: A Retrospective Case Series Authors: George-Joseph Melki, Jelle Demeestere, Annouschka Laenen, Lawrence Bonne, Eveline Claus, Julie Lambert, Pieter-Jan Buyck, Jo Peluso, Philippe Demaerel, Robin Lemmens, Geert Maleux Journal: World Neurosugery Background: - [89-PATIENT SINGLE-CENTER EXPERIENCE](https://www.vesalio.com/neva-publications/89-patient-single-center-experience/) - 89-PATIENT SINGLE-CENTER EXPERIENCE Paper: The NeVa stent-retriever – a single-centre, real-world experience Authors: Pervinder Bhogal, Marco Mancuso-Marcello , Rory Fairhead, Katherine Parkin, Giovanna Klefti, Levansri Makalanda , Ken Wong, Joseph Lansley, Karthikeyan Vanchilingham, Michael Przyszlak, Rukhtam Saqib, Oliver Spooner Journal: Interventional Neuroradiology – MAY 2025 Background: Stent-retriever-based mechanical thrombectomy (MT) is an effective treatment for - [NEVA NET 5.5 FIRST CLINICAL MULTICENTER EXPERIENCE](https://www.vesalio.com/neva-publications/neva-net-5-5-first-clinical-multicenter-experience/) - NEVA NET 5.5 FIRST CLINICAL MULTICENTER EXPERIENCE Paper: First clinical multicenter experience of the new NeVa NET 5.5 thrombectomy device Authors: Roland Schwab, Balázs Kis, Berki Alexandra Réka, Janos Sebestyen Gellen, Katharina Haider, Eya Khadhraoui, Sebastian Johannes Müller, Erelle Fuchs, Maximilian Thormann, Johannes Alex Rolf Pfaff, Daniel Behme Journal: Journal of Neuro-Interventional Surgery – JUNE - [NEVA VS EARLY EXPERIENCE AT SNIS 2024](https://www.vesalio.com/neva-vs-publications/neva-vs-snis24/) - Early multi-center experience with the NeVa VS in the treatment of subarachnoid hemorrhage-related cerebral vasospasm Authors: Clemens M. Schirmer, Shahid Nimjee, Eric Savageau, Michael Chen, Ameer E. Hassan Journal: Journal of NeuroInterventional Surgery INTRODUCTION: Cerebral vasospasm represents a formidable challenge in the aftermath of subarachnoid hemorrhage (SAH), significantly contributing to morbidity and mortality. This life-threatening - [NEVA VS VITAL STUDY](https://www.vesalio.com/clinical/neva-vs-vital/) - PRIMARY RESULTS OF THE VESALIO NEVA VS FOR THE TREATMENT OF SYMPTOMATIC CEREBRAL VASOSPASM FOLLOWING ANEURYSM SUBARACHNOID HEMORRHAGE (VITAL) STUDY Authors: Rishi Gupta, Keith Woodward, David Fiorella, Henry H Woo, David Liebeskind, Donald Frei, Adnan Siddiqui, Reade De Leacy, Ricardo Hanel, Lucas Elijovich, Alberto Maud for the VITAL Study Investigators Journal: Journal of NeuroInterventional Surgery - [US Territory Manager](https://www.vesalio.com/about/careers/us-territory-manager/) - US Territory Manager Department: Sales Reports To: VP U.S. Sales Territory Location: Florida POSITION DESCRIPTION: Drive sales & market share growth of Vesalio products in the defined territory drawing upon proven endovascular sales experience & exceptional territory and account management skills. Duties and Responsibilities: Drive sales performance to meet/exceed company objectives in a defined territory: - [NeVa Net IFU](https://www.vesalio.com/technology/discover-neva-net/neva-net-ifu/) - NeVa Net Instructions for Use Under construction - [Terms of use](https://www.vesalio.com/terms-of-use/) - TERMS OF USE PLEASE READ THIS PRIVACY STATEMENT CAREFULLY. These Terms of Use describe rules for visitors to this Vesalio website. This website is owned and operated by Vesalio. Vesalio is the name we use to refer to our whole business, including Vesalio plc and any of the companies that it controls, including subsidiaries and - [NeVa Neuro Thrombectomy](https://www.vesalio.com/technology/neva-neuro-thrombectomy/) - NEURO THROMBECTOMY NeVa™ Taking Clot Capture to the Next Level with Drop ZoneTM Technology The NeVa Neuro Thrombectomy consists of 3 Drop Zones to make one pass instead of multiple passes. Unique to NeVa, the Drop Zones are large, open pockets, offset at 90° to one another on the NeVa™ stent structure. They are designed - [Privacy Policy](https://www.vesalio.com/privacy-policy/) - PRIVACY POLICY PLEASE READ THIS PRIVACY STATEMENT CAREFULLY. Privacy is very important to us. We also understand that privacy is very important to you. This Privacy Statement tells you how we protect and use information that we gather through this Vesalio website based in the U.S. Vesalio. By using this website, you agree to the - [NEVA VS EARLY EXPERIENCE AT SNIS 2024](https://www.vesalio.com/neva-publications/neva-vs-early-experience-at-snis-2024/) - E-102 Early multi-center experience with the NeVa VS in the treatment of subarachnoid hemorrhage-related cerebral vasospasm Paper: E-102 Early multi-center experience with the NeVa VS in the treatment of subarachnoid hemorrhage-related cerebral vasospasm Authors: Clemens M. Schirmer, Shahid Nimjee, Eric Savageau, Michael Chen, Ameer E. Hassan, Geisinger Journal: Journal of Neuro-Interventional Surgery Background: Cerebral vasospasm represents a - [NeVa First Man](https://www.vesalio.com/neva-publications/neva-first-man/) - NEVA FIRST IN MAN Paper: Mechanical thrombectomy with a novel stent retriever with multifunctional zones: Initial clinical experience with the NeVa™ thrombectomy device Authors: Ribo, Requena, Macho, Zamarro, Machi, Hernandez, Blasco, Tomasello Journal: Journal of Neuroradiology – 2019 Background and Purpose: The NeVa™ (Vesalio, Nashville, Tennessee) thrombectomy device is a CE-approved novel hybrid-cell stent retriever - [NEVA CLEAR: A PROSPECTIVE, INTERNATIONAL, MULTICENTER IDE STUDY TO EVALUATE THE DROP ZONE TECHNOLOGY](https://www.vesalio.com/neva-publications/neva-clear-a-prospective-multicenter-ide-study/) - NEVA CLEAR: A PROSPECTIVE MULTICENTER IDE STUDY Paper: Primary results from the CLEAR study of a novel stent retriever with Drop Zone technology Authors: Albert J Yoo, Serdar Geyik, Michael T Froehler, Christoph Johannes Maurer, Tareq Kass-Hout, Osama O Zaidat, Raul G Nogueira, Ricardo A Hanel, Laurent Pierot, Laurent Spelle, Demetrius Lopes, Ameer Hassan, Audrius - [InVitro Evaluation of NeVa1](https://www.vesalio.com/neva-publications/invitro-evaluation-of-neva/) - IN-VITRO EVALUATION OF NEVA Paper: Experimental evaluation of the NeVa™ thrombectomy device, a novel stent retriever conceived to improve efficacy of organized clot removal Authors: Machi, Ulm, Bernava, Brina, Lovbad, Jourdan Journal: Journal of Neuroradiology – 2017 Background and Purpose: Although stent-retrievers are recognized as the most effective devices in thrombectomy, they still fail when - [IN VITRO EVALUATION OF NEVA NET AGAINST SOLITAIRE AND EMBOTRAP](https://www.vesalio.com/neva-publications/in-vitro-evaluation-of-neva-net/) - IN VITRO EVALUATION OF NEVA NET™ AGAINST SOLITAIRE AND EMBOTRAP Paper: Impact of stent-retriever tip design on distal embolization during mechanical thrombectomy: a randomized in vitro evaluation. Authors: Jiahui Li, Riccardo Tiberi, Pervinder Bhogal, Jan-Hendrik Buhk, Daniel Behme, Alejandro Tomasello, Marc Ribo Journal: Journal of Neuro-Interventional Surgery– MAY 2023 Background: Repeated number of passes, clot - [FIRST-LINE AND RESCUE EXPERIENCE WITH NEVA](https://www.vesalio.com/neva-publications/first-line-and-rescue-experience-with-neva/) - Evaluation of effectiveness and safety of the multizone NeVa™ stent retriever for mechanical thrombectomy in ischemic stroke. FIRST-LINE AND RESCUE EXPERIENCE WITH NEVA Paper: Evaluation of effectiveness and safety of the multizone NeVa™ stent retriever for mechanical thrombectomy in ischemic stroke. Authors: Max Masthoff, Hermann Krähling, Burak Han Akkurt, Mohamed Elsharkawy, Michael Köhler, Mostafa Ergawy, Christian Thomas, Wolfram Schwindt, Jens Minnerup & Paul Stracke Journal: Interventional Neuroradiology Purpose: This study aimed to - [Drop Zone Risk Or Benefit NeVa](https://www.vesalio.com/neva-publications/29-patient-single-center-experience/) - 29-PATIENT SINGLE-CENTER EXPERIENCE Paper: Mechanical Thrombectomy with the Novel NeVa M1 Stent Retriever: Do the Drop Zones Represent a Risk or a Benefit? Authors: Jan Borggrefe, Lukas Goertz, Nuran Abdullayev, Nils Große Hokamp, Christina Maria Kowoll, Özgür Onur, Christoph Kabbasch, Marc Schlamann Journal: World Neurosurgery – DECEMBER 2020 Objective: The NeVa M1 thrombectomy device is - [145-PATIENT EXPERIENCE OF NEVA IN FIRST-LINE USE](https://www.vesalio.com/neva-publications/145-patient-experience-of-neva-in-first-line-use/) - First pass results of mechanical thrombectomy with two-drop zone NeVa™ device - [118-Patient Multi-Center Experience NeVa](https://www.vesalio.com/neva-publications/118-patient-multi-center-experience/) - 118-PATIENT MULTI-CENTER EXPERIENCE Paper: Favorable first-pass recanalization rates with NeVa™ thrombectomy device in acute stroke patients: Initial clinical experience Authors: Cetin K Akpinar, Atilla O Ozdemir, Erdem Gurkas, Adnan B Bilgic, Ozlem Aykac, Yusuf Inanc, Semih Giray Journal: Interventional Neuroradiology – JULY 2020 Background: The NeVa thrombectomy device (Vesalio LLC, Nashville, USA) has been reported - [SINGLE PASS TICI 3 WITH NeVa NET in AN MCA-M1 occlusion](https://www.vesalio.com/clinical-cases/neva-case-13-kalousek2-m1-1stpass-55mmnet/) - SINGLE PASS TICI 3 WITH NeVa NET in AN MCA-M1 occlusion NeVa™ NET 5.5 x 37 mm Dr Vladimir KALOUSEK, UHC Sisters of Charity, Zagreb, CROATIA Clinical Case Report Presentation 86-year-old female patient presenting with a NIHSS of 12 was referred with an IV-tPA (drip & ship) from the primary care centre. The exact time of - [NeVa Saves the Day after 5 Failed Passes](https://www.vesalio.com/clinical-cases/neva-case-11-dorobat1-1stpassafter5passordeal/) - NeVa Saves the Day after 5 Failed Passes NeVa™ 4.5 x 37 mm Bucharest University Emergency Hospital Stroke Team Clinical Case Report Presentation 80 year old male patient presented with a NIHSS of 24, 4 hr 15 min after symptom onset. The patient was transferred to the Bucharest University Emergency Hospital Stroke Unit after tPA - [NeVA Case 9 Jena University](https://www.vesalio.com/clinical-cases/neva-case-9-mayer1-m1-1stpass/) - Impact of 1st PASS in early-onset stroke NeVa™ 4.0 x 30 mm Presentation 55 year old stroke patient presented with hemiplegia and aphasia. Imaging confirmed a left MCA (M1) occlusion. The CBF map confirmed the existence of significant salvageable penumbra in the occluded area. Professor Thomas Mayer,Head of INR DepartmentJena University, Germany The Procedure Professor - [NeVA Case 8 Mauer](https://www.vesalio.com/clinical-cases/neva-case-8-maurer1-m1-1stpass/) - 1ST PASS SUCCESS WITH THE 3 DROP ZONE NEVA IN A LEFT M1 OCCLUSION NeVa™ T-3S (4.5 x 29 mm) Clinical Case Report Presentation ​92 year old female patient living alone and fully independently presented with a NIHSS of 21. The patient had right hemiplegia, global aphasia and was somnolent. Imaging confirmed a Left MCA - [NeVa Case 7 LINNC Masterclass](https://www.vesalio.com/clinical-cases/neva-case-7-mihalea1-tandem-at-linnc/) - NEVA IN TANDEM STROKE: CASE FROM LINNC MASTERCLASS NeVa™ M1 (4 x 30 mm) Courtesy of Neuri Bicetre, Prof Spelle, & Prof Moret Chapters 00:29 Introduction03:46 Discussion on Treatment Strategy18:01 Carotid Stent Placement in the ICA20:10 Thrombectomy of the MCA Occlusion 24:19 Thrombectomy of the ACA Occlusion 27:05 Case Summary & Follow Up28:17 Discussions and - [NeVa Case 6 Tomasello ICATip Kissing](https://www.vesalio.com/clinical-cases/neva-case-6-tomasello1-icatip-kissing-rescue/) - SINGLE NEVA RESCUES KISSING RETRIEVERS IN CAROTID T OCCLUSION NeVa™ 6.0 x 44 mm Clinical Case Report Presentation 69 year old male patient presented with a NIHSS of 22, two and a half hours after symptom onset. Imaging confirmed occlusion of distal left internal carotid artery​ (carotid-T occlusion). Dr. Alejandro Tomasello Vall d’Hebron HospitalBarcelona/ SPAIN - [NeVa Case 14 Petra1 M1 1st Pass 4 mm Net](https://www.vesalio.com/clinical-cases/neva-case-14-petra1-m1-1stpass-4mmnet/) - COMPLETE FIRST-PASS RECAN WITH NEVA NET 4 MM IN A RIGHT M1 OCCLUSION NeVa NET 4.0 x 30 mm Dr Fernando Ezequiel PETRA, Hospital Santa Isabel de Hungria, Mendoza, ARGENTINA Clinical Case Report Presentation 77-year-old female patient presented with an NIHSS of 18 5 hours 22 min from symptom onset No IV Rtpa administered Right - [NeVa Case 10 Cerrahpasa](https://www.vesalio.com/clinical-cases/neva-case-10-kizilkilic1-1stpassaftercarotidblowout/) - ONE-PASS M2 RECANALIZATION AFTER CAROTID BLOWOUT REPAIR NeVa™ 4.0 x 22 Clinical Case Report Presentation 64 year old Male patient with history of nasopharyngeal cancer (NPC) treated with radiotherapy 12 years ago. Recurrent tumor was identified during follow up. During biopsy performed under general anesthesia, profuse bleeding occurred at the early stages of the procedure and - [Medical Park NeVa Case 2](https://www.vesalio.com/clinical-cases/neva-case-2-geyik2-m2-rescue/) - NeVa™ TO THE RESCUE 1st Pass Success with NeVaTM M1S (4.0 x 22 mm) after failure of 2 different devices Clinical Case Report Presentation 75 year old female patient presented with NIHSS of 19 presented 4 hours after symptom onset. It was noted that the patient had had a knee implant surgery 3 days prior to - [Medical Park NeVa Case 1](https://www.vesalio.com/clinical-cases/neva-case-1-geyik1-m1-1stpass/) - WAKE UP STROKE Left M1 Occlusion 1st Pass Success with NeVa™ M1 (4.0 x 30 mm) Clinical case Report PRESENTATION 81 year old make patient presented with NIHSS of 21. The Patient was last seen well 6.5 hours ago. Imaging confirmed Left MCA occlusion. Professor Dr. Serdar GeyikIstanbul Istinye University Medical Park Hospital Istanbul, Turkey PRE-OP - [First Pass TICI 3 In The Right Posterior Cerebral Artery](https://www.vesalio.com/clinical-cases/neva-case-16-gramada1-1stpasstici3-in-rpca/) - A First Pass TICI 3 In The Right Posterior Cerebral Artery NeVa™ 4.0 x 22 mm Dr. Lucian Gramada, Dr. Huda ElmoulaUniversitätsklinikum Witten/ Herdecke, Germany Clinical Case Report Presentation 85-year-old male patient presented with a NIHSS of 2 within the mechanical thrombectomy eligibility time window. No IV-tPA was administered. Dr. Lucian GramadaUniversitätsklinikum Witten/HerdeckeWitten, Germany Dr. Huda - [Dual Stent Retriever Technique With NeVa In A Centenarian Patient](https://www.vesalio.com/clinical-cases/neva-case-15-cohen1-dualsr-with-neva-in-centenarian/) - DUAL STENT RETRIEVER TECHNIQUE WITH NeVa in A CENTENARIAN PATIENT NeVa 4.5 x 29 mm Prof Jose COHEN,Hadassah Medical Center, Jerusalem, ISRAEL Clinical Case Report Presentation Centenarian female patient (105 YO) presented with a NIHSS of 19, five hours after symptom onset Imaging confirmed occlusion of the distal left internal carotid artery, carotid-T and the - [Dual Stent Retriever Technique With NeVa For First Pass Success](https://www.vesalio.com/clinical-cases/neva-case-17-cohen2-dualsr-in-ica-1stpass/) - Dual Stent Retriever Technique With NeVa For First Pass Success NeVa 5.5 x 37 mm Prof Jose COHEN,Hadassah Medical Center, Jerusalem, ISRAEL Clinical Case Report Presentation 87 YO male patient presented with a NIHSS of 24. The patient was last time seen well 7 hours ago. The patient had a history of congestive heart failure - [A Proximal Occlusion: One and Done](https://www.vesalio.com/clinical-cases/neva-case-3-geyik3-proximal-one-and-done/) - A PROXIMAL OCCLUSION: ONE AND DONE Right ICA Tip Occlusion 1st Pass Success with NeVa™ T (4.5 x 37 mm) Clinical Case Report Presentation 75 year old female patient presented with NIHSS of 14. Time from Onset was 1,5 hours at the time of admission to Medical Park stroke center. ​The patient had a medical - [Audrius Sirvisnkas Basilar Case T3S](https://www.vesalio.com/clinical-cases/neva-case-5-sirvinskas1-ba-1pass/) - 1st PASS SUCCESS INBASILAR WAKE UP STROKE With the 3 Drop Zone NeVa™ 4.5 x 29 mm Clinical Case Report Presentation Wake up stroke 68 year old female patient last seen well >10 hours ago, presenting with a NIHSS of 8. Imaging confirmed Basilar Occlusion and a Stenosis at the AICA Segment. Dr. Audrius SirvinskasRepublic - [A FIRST PASS TICI 3 IN THE LEFT MCA](https://www.vesalio.com/clinical-cases/neva-case-18-gramada2-1stpasstici3-in-lm1/) - A FIRST PASS TICI 3 IN THE LEFT MCA NeVa™ 4.0 x 30 mm Dr. Lucian Gramada, Dr. Huda ElmoulaUniversitätsklinikum Witten/ Herdecke, Germany Clinical Case Report Presentation 58-year-old female patient presented with: Right side Hemiplegia, Aphasia and Hemineglect NIHSS of 17 The patient was in the mechanical thrombectomy eligibility time window and no IV-tPA was - [1st Pass in Stroke with Unknown Onset](https://www.vesalio.com/clinical-cases/neva-case-4-kalousek1-m1-1stpass/) - 1st PASS IN STROKE WITH UNKNOWN ONSET Right M1 Occlusion 1st Pass Success with NeVa™ M1 (4.0 x 30 mm) Clinical Case Report Presentation 88 year old female patient presented with a NIHSS of 15. The patient was found on the floor of her bathroom, with left side hemiplegia. Her pre-stroke mRS was assessed to be 0.​Native CT - [JAAC 2023](https://www.vesalio.com/envast-publications/envast-jacc-2023/) - EnVast Mechanical Thrombectomy After Thrombus Aspiration Failure in a STEMI With a Massive Thrombotic Burden Publication Review - [Contact](https://www.vesalio.com/contact/) - Reach Out Contact Us "*" indicates required fields Comments This field is for validation purposes and should be left unchanged. First Name* Last Name* Email* Phone Organization* Nature of Inquiry Consent* I accept the privacy policy.* - [Product Manager Neurovascular](https://www.vesalio.com/about/careers/product-manager-us/) - Product Manager Department: Sales & Marketing Reports To: VP Market DevelopmentVP U.S. Sales POSITION DESCRIPTION: Under the direction of the VP of Market Development and the VP of U.S. Sales, the Product Manager (PM) will play a crucial role in driving downstream marketing consistent with overall Vesalio business objectives. The PM will drive the tactical - [NEVA VS VITAL STUDY](https://www.vesalio.com/neva-publications/neva-vs-vital-study/) - Primary results of the Vesalio NeVa VS for the Treatment of Symptomatic Cerebral Vasospasm following Aneurysm Subarachnoid Hemorrhage (VITAL) Study Paper: Primary results of the Vesalio NeVa VS for the Treatment of Symptomatic Cerebral Vasospasm following Aneurysm Subarachnoid Hemorrhage (VITAL) Study Authors: Rishi Gupta, Keith Woodward, David Fiorella, Henry H Woo, David Liebeskind6 Donald Frei, - [Pre-Clinical Evaluation of NeVa Net](https://www.vesalio.com/neva-publications/pre-clinical-evaluation-of-neva-net/) - PRE-CLINICAL EVALUATION OF NEVA NET Paper: Preclinical safety and efficacy of the NeVa NET™: A novel thrombectomy device with integrated embolic distal protection Authors: Vania Anagnostakou MD PhD, Raul G. Nogueira MD, Mark Epshtein, PhD, Matthew J Gounis PhD, Daniel Behme MD, Arthur Ulm MD, Rishi Gupta MD Journal: Journal of Vascular and Interventional Neurology - [Vision & History](https://www.vesalio.com/about/vision-history/) - LEARN ABOUT OUR VISION & HISTORY Why is Vesalio Driven to Advance Stroke Treatment Ischemic Stroke is a devastating acute condition with a high risk of loss of life or neurological function. It is an emergency condition, where death rapidly spreads through brain tissue and every minute is crucial. Today, thanks to highly trained neuro-endovascular ## Categories - [Neva](https://www.vesalio.com/category/neva/) - [Blog Articles](https://www.vesalio.com/category/blog-articles/) - [Press Releases](https://www.vesalio.com/category/press-releases/) - [Media](https://www.vesalio.com/category/media/) - [NeVa Training & Internal Reporting](https://www.vesalio.com/category/media/training/) - [NeVa Customer Facing Tools](https://www.vesalio.com/category/media/customer-facing-tools/) - [enVast Training & Internal Use](https://www.vesalio.com/category/media/envast-training-internal-use/) - [enVast Customer Facing Tools](https://www.vesalio.com/category/media/envast-customer-facing-tools/) - [enVast Clinicals](https://www.vesalio.com/category/media/envast-clinicals/) - [pVasc Customer Facing Tools](https://www.vesalio.com/category/media/pvasc-customer-facing-tools/) - [pVasc Training & Internal Reporting](https://www.vesalio.com/category/media/pvasc-training-internal-reporting/) - [Neva VS Customer Facing Tools](https://www.vesalio.com/category/media/neva-vs-customer-facing-tools/) - [NeVa VS Training & Internal Reporting](https://www.vesalio.com/category/media/neva-vs-training-internal-reporting/) ## Tags - [Neva VS](https://www.vesalio.com/tag/neva-vs/) - [Neva Net](https://www.vesalio.com/tag/neva-net/) - [pVasc](https://www.vesalio.com/tag/pvasc/) - [US](https://www.vesalio.com/tag/us/) - [International](https://www.vesalio.com/tag/intl/) - [Neva Clear](https://www.vesalio.com/tag/neva-clear/) - [Neva](https://www.vesalio.com/tag/neva/)